Prognos Health Announces Patent-Pending Technology
Learn More
Skip to content
prognos-logo-light Prognos Health
Main Menu
  • Support
  • Client Login
  • Request Demo
  • prognosFACTOR®
    • Prognos Marketplace
  • Products
    • Life Sciences
      • Cohort Designer
      • Patient Journey
      • Physician Segmentation
      • Outcomes
      • Alerts
      • Omnichannel Marketing
    • Payers
      • Underwriting Risk Predictor
      • Risk Adjustment & Quality Analytics
  • Company
    • Careers
    • Events
    • News
    • Insights
  • Contact Us
Home Insights Reflections on the PMSA Winter Symposium

Reflections on the PMSA Winter Symposium

  • January 23, 2019
  • Posted in AI

This post was last updated on January 7, 2020 at 2:20 pm

PMSA Logo

By Theresa Greco, Chief Commercial Officer

The PMSA Winter Symposium, “Innovation in Analytics via Machine Learning & AI” brought together industry leaders in data science and analytics to share experience and knowledge on real world applications of ML/AI within Life Sciences.  Expert speakers and panelists shared deep insights with a focus on three areas: innovation, application, and collaboration.

  1. Innovation: The Industry investment in data science is alive and well as organizations continue to invest in strategies that deliver data-driven insights. Data acquisition strategies continue to expand the data fabric that informs model development and feature engineering. The expanding variety of data sources, when combined, help to identify new relationships that exist between variables and close missing data gaps.  This allows identification of relationships that simply are not accessible when the sources are kept separate or are missing. Innovative applications of data science are applied to yield better insights faster.
  2. Application: There is a strong appetite for applications of ML/AI across the commercial lifecycle with key areas identified as segmentation, targeting, field and non-personal promotion, patient journeys, and forecasting, among others.  Identification of the optimal patient for treatment in the world of personalized medicine is a real focus where AI applications can add significant value to help patients get the proper treatment at the right time in their journey.
  3. Collaboration: There is a strong desire for collaboration between data science and business stakeholders and a common perspective that both parties need to embrace the expertise and value being offered by the other in order to solve some of the most challenging business questions facing the industry today.  The external partner landscape provides an additional layer of value and collaboration where domain experts complement the talents that exist within.

A recent WSJ article highlighting the value of startups in healthcare AI, featured Prognos as an innovative startup that applies best-in-class AI to clinical data to drive the right decisions earlier and improve health. The vast diagnostic data housed in the Prognos Registry is exactly the type of data that helps inform treatment and outcomes. The innovation of Prognos data scientists in applying AI to diagnostic and clinical data has real predictive power that is helping to identify ideal patients earlier in their disease progression in many broad, oncological and rare conditions so that patients can be matched with the optimal treatment at the optimal time. Prognos will continue to innovate and partner with the industry to improve health outcomes.

« The Value of Using Lab Data
Innovative Models for Converting AI Data »

Categories

  • AI
  • Alerts
  • Clinical
  • Commercial Launch Excellence
  • Disease Awareness
  • Lab Testing Insights
  • Lab Testing Trends
  • Marketplace
  • Omnichannel Marketing
  • Physician Segmentation
  • Prog Spotlight
  • Technology
  • Underwriting

Archives

Latest Tweets

Prognos HealthFollow

Prognos Health
prognosAIPrognos Health@prognosAI·
6 Apr

Prognos Health announces patent-pending technology, FACTOR Logic™, to manage healthcare-specific data at web speeds. https://bit.ly/3upyBu0

#prognosFACTOR #FACTORLogic #HealthcareAnalytics #HealthcareData

Reply on Twitter 1379498734472560640Retweet on Twitter 13794987344725606401Like on Twitter 13794987344725606401Twitter 1379498734472560640
prognosAIPrognos Health@prognosAI·
1 Apr

Prognos Co-founder, @jmbhan, discusses commercial launch excellence with leaders from @Novartis, @TakedaPharma, and @pfizer. Explore 9 key insights uncovered from these innovators in #pharma. https://bit.ly/3mb0T8y

#PatientCohorts #ClinicalData #LaunchExcellence #LifeSciences

Reply on Twitter 1377714666487619584Retweet on Twitter 13777146664876195841Like on Twitter 1377714666487619584Twitter 1377714666487619584
prognosAIPrognos Health@prognosAI·
30 Mar

Frequently used data sources for aggregate #risk prediction scores aren’t as complete as they could be. This can open you up to financial losses. Learn how #LabData fills gaps and improves #underwriting accuracy. https://bit.ly/31ytJpW

#RiskAssessment #UnderwritingRisk

Reply on Twitter 1376937839859019777Retweet on Twitter 13769378398590197771Like on Twitter 13769378398590197771Twitter 1376937839859019777
prognosAIPrognos Health@prognosAI·
16 Mar

Prognos and @DatavantHQ extend their partnership to enable the rapid acquisition and integration of fit-for-purpose real-world datasets for life sciences. Learn more: https://prognoshealth.com/about-us/news/press-release/prognos-health-and-datavant-extend-partnership/

#RealWorldData #RWD #Pharma #LifeSciences #prognosFACTOR #PrognosMarketplace

Reply on Twitter 1371816650018852869Retweet on Twitter 13718166500188528692Like on Twitter 13718166500188528691Twitter 1371816650018852869
prognosAIPrognos Health@prognosAI·
12 Mar

Acquiring and applying #RealWorldData is undergoing a transformation. Processes related to purchasing, storing, integrating, and analyzing de-identified #PatientData are all being streamlined. Discover how:

https://prognoshealth.com/blog/lowering-the-stakes-of-real-world-data-purchases/

#RWD #PrognosMarketplace #Pharma #LifeSciences

Reply on Twitter 1370416384426045452Retweet on Twitter 13704163844260454521Like on Twitter 1370416384426045452Twitter 1370416384426045452
Load More...
  • prognosFACTOR®
    • Prognos Marketplace
  • Products
    • Life Sciences
    • Payers
  • Company
    • Insights
    • Careers
    • Events
    • News
  • LinkedIn
  • Twitter
  • YouTube
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Site Map
© Prognos Health, 2021. All Rights Reserved.

See What Decision Speed Looks Like in Action

To give you the best possible experience, this site uses cookies and by continuing to use the site you agree that we can save them on your device. For more details about cookies and their use, please see our Privacy Policy.